drugset / Trial / NCT06081738
Neostigmine Versus Sugammadex on Renal Functions
RandomizedParallel-groupDouble-blindDiagnostic
Summary
The study will assess the acute effects of sugammadex or neostigmine on renal function as determined with more specific and sensitive tests in laparoscopic cholecystectomy
Timeline
- Start
- 2023-03-01
- Primary completion
- 2023-09-01
- Completion
- 2023-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Neostigmine | Other / unclassified | 0.04 mg/kg | Intravenous |
| Comparator | Sugammadex | Other / unclassified | 2 mg/kg | Intravenous |
| Comparator | Sugammadex | Other / unclassified | 4 mg/kg | Intravenous |
| Comparator | Atropine | Other / unclassified | 0.01 mg/kg | Intravenous |
Indications
No indication recorded.